You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Drugs Containing Excipient (Inactive Ingredient) CITRIC ACID ACETATE


✉ Email this page to a colleague

« Back to Dashboard


CITRIC ACID ACETATE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Citric Acid in the Pharmaceutical Sector

Introduction to Citric Acid in Pharmaceuticals

Citric acid, a versatile and widely used compound, plays a crucial role in the pharmaceutical industry. Its multifaceted applications, from acting as an excipient to enhancing the stability and efficacy of medications, make it an indispensable component in pharmaceutical formulations.

Global Market Size and Growth

The global citric acid market, which includes its pharmaceutical applications, was valued at USD 3,786.9 million in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 4.0% from 2023 to 2030, reaching USD 5.17 billion by 2030[1].

Pharmaceutical Applications of Citric Acid

Role as an Excipient

Citric acid is predominantly used as an excipient in pharmaceutical formulations. It serves multiple functions, including stabilizing pH levels, acting as a chelating agent, and ensuring the stability and efficacy of diverse medications. This versatility makes citric acid a critical component in the production of various pharmaceutical products[1].

Effervescent Tablets

In the production of effervescent tablets, citric acid is a vital component responsible for creating effervescence. This enhances patient compliance with the medication regimen, as the tablets are easier to consume and more palatable[1].

Market Segmentation and Trends

Application Outlook

The pharmaceutical segment is expected to register a CAGR of 4.2% over the forecast period, driven by the increasing demand for citric acid in the manufacturing of digestive medicines and other pharmaceutical products. The food and beverage sector, however, dominates the citric acid market with a share of 71.4% in 2022, but the pharmaceutical sector is growing steadily[1].

Regional Outlook

Central and South America are expected to grow at a CAGR of 4.7% during the forecast period, driven by the region's burgeoning middle-class population and expanding food, beverage, pharmaceutical, and personal care industries. This growth is also fueled by rising disposable incomes and urbanization, leading to increased demand for citric acid[1].

Price Trends and Market Dynamics

Global Price Trends

The price of citric acid has been influenced by various factors, including inventory levels, demand from downstream industries, and environmental regulations. In Europe, stricter environmental regulations and higher energy costs have increased production costs, leading to higher citric acid prices. In North America, the dynamics of the corn market, a key raw material in citric acid production, have also impacted prices[2].

Regional Price Variations

In Asia, the citric acid price trend has been affected by the recovery of China’s manufacturing industries and the rising cost of raw materials. The increased demand from downstream industries, such as food and pharmaceuticals, has also driven up prices. In contrast, weak consumer demand in Europe, especially in the food and beverage sectors, has exacerbated pricing challenges[2].

Key Players and Market Competition

The citric acid market is competitive, with several key players operating globally. These include Metagenics, Inc., MP Biomedicals, Tate & Lyle plc, DuPont Danisco, Cargill Incorporated, Kenko Corporation, Pfizer, Inc., and Archer Daniels Midland (ADM) Company. These companies are investing in research and development to enhance the quality and applications of citric acid, further driving market growth[1].

Drivers and Barriers

Drivers

  • Increasing Demand for Preventive Healthcare: The growing emphasis on preventive healthcare, coupled with a rising geriatric population, has increased the demand for citric acid in pharmaceutical formulations.
  • Growing Pharmaceutical Excipients Market: The global pharmaceutical excipients market, which includes citric acid, is forecasted to grow from USD 10.0 billion in 2023 to USD 13.9 billion by 2028, driven by a CAGR of 6.8%. This growth is attributed to the increasing demand for generic drugs and patient-centric formulations[3].

Barriers

  • Regulatory Stringency: Growing regulatory stringency and high investments in development costs are predicted to cause market growth barriers.
  • Economic Challenges: Softening economic conditions in some regions and higher energy costs can exacerbate pricing challenges and affect market growth[2][3].

Financial Trajectory

The financial trajectory of citric acid in the pharmaceutical sector is positive, with steady growth anticipated over the forecast period. Here are some key financial highlights:

  • Market Size: The global citric acid market is expected to reach USD 5.17 billion by 2030, growing at a CAGR of 4.0% from 2023 to 2030[1].
  • Segment Growth: The pharmaceutical segment is expected to register a CAGR of 4.2% over the forecast period, contributing significantly to the overall market growth[1].

Regional Financial Outlook

  • Central and South America: This region is expected to grow at a CAGR of 4.7% during the forecast period, driven by expanding industries and rising disposable incomes[1].
  • North America: Despite challenges such as elevated transportation costs and supply chain disruptions, the demand for citric acid in North America remains strong, particularly in the food and beverage sectors[2].

Key Takeaways

  • Citric acid is a critical excipient in pharmaceutical formulations, enhancing stability and efficacy.
  • The global citric acid market is expected to grow at a CAGR of 4.0% from 2023 to 2030.
  • The pharmaceutical segment is anticipated to register a CAGR of 4.2% during the forecast period.
  • Regional growth, especially in Central and South America, is driven by expanding industries and rising disposable incomes.
  • Price trends are influenced by factors such as inventory levels, demand from downstream industries, and environmental regulations.

Frequently Asked Questions

What is the current market size of citric acid and its expected growth rate?

The global citric acid market was valued at USD 3,786.9 million in 2022 and is expected to grow at a CAGR of 4.0% from 2023 to 2030, reaching USD 5.17 billion by 2030[1].

How is citric acid used in pharmaceutical formulations?

Citric acid is used as an excipient to stabilize pH levels, act as a chelating agent, and ensure the stability and efficacy of medications. It is also crucial in the production of effervescent tablets[1].

Which region is expected to grow the fastest in terms of citric acid demand?

Central and South America are expected to grow at a CAGR of 4.7% during the forecast period, driven by the region's burgeoning middle-class population and expanding industries[1].

What are the key drivers of the citric acid market in the pharmaceutical sector?

Key drivers include increasing demand for preventive healthcare, a rising geriatric population, and the growing demand for generic drugs and patient-centric formulations[1][3].

How do environmental regulations affect the price of citric acid?

Stricter environmental regulations, particularly in Western and Central Europe, have forced manufacturers to invest in more sustainable production processes, leading to increased production costs and higher citric acid prices[2].

Cited Sources

  1. Grand View Research - Citric Acid Market Size, Share & Trends Analysis Report 2030
  2. Procurement Resource - Citric Acid Price Trend, News, Database, Chart, Forecast
  3. MarketsandMarkets - Pharmaceutical Excipients Market Growth, Drivers, and Opportunities
  4. Data Bridge Market Research - Global Citric Acid Market
  5. Credence Research - Citric Acid Market Size, Growth, Analysis & Forecast 2032

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.